Immunogenicity Study of the Recombinant Human Papillomavirus Virus Type 6/11 Bivalent Vaccine
Clinical trial NCT02710851 · UNKNOWN
Trial details
- NCT number
- NCT02710851
- Sponsor
- Jun Zhang
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-24
- Primary completion
- 2023-12-30
- Enrollment
- 640
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.